EUCTR2006-000381-36-GB进行中（未招募）不适用
Randomised controlled trials to investigate whether prophylactic antibiotics can prevent further episodes of cellulitis (erysipelas) of the leg (PATCH I & PATCH II) - PATCH I & PATCH II
niversity of Nottingham0 个研究点目标入组 640 人开始时间: 2006年2月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 640
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •(1) Diagnosis of cellulitis of either leg (index episode)
- •(2) History of at least one previous episode of cellulitis of either leg within the three years prior to the index episode.
- •(1) Diagnosis of cellulitis of either leg (index episode)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any doubt about the certainty of the diagnosis of either the index episode or the previous episode (if applicable), will be grounds for exclusion. Additionally, patients with any of the following will be excluded:
- •(1)Already taking prophylactic antibiotics for the prevention of cellulitis prior to index episode.
- •(2)A time lapse of longer than 26 weeks since the start of treatment for the index episode to the date of potential randomisation into the trial.
- •(3)Known allergy to penicillin. Prospective participants will be questioned as to the nature of their previous allergic reaction in order to assess whether it was a true allergic response or simply an intolerance to the antibiotic. This questioning will address the following points:
- •i)whether the patient experienced a rash;
- •ii)when the reaction occurred in relation to administration of the drug;
- •iii)which type of penicillin they had.
- •Should the clinician believe the reaction to have been intolerance rather than an allergic reaction, the clinician will talk the issue through with the patient. The final decision as to whether to take part in the trial will obviously rest with the patient.
- •(4)Preceding leg ulceration, surgery or penetrating trauma, as these cases are more likely to be caused by staphylococcal infection. (NB: this does not exclude patients with toeweb maceration/tinea pedis or other minor/blunt wounds).
- •(5)Treating physician or principal investigator unwilling to randomise patient. This includes, but is not limited to:
- •i)the treating physician recommends that the patient requires prophylactic antibiotics (ie not willing/able to accept randomisation);
- •ii)concomitant medication that would mean that long-term penicillin VK is inappropriate;
- •iii)diagnostic uncertainty;
- •iv)confounding concurrent disease (eg DVT).
- •(6)Aged less than 16 years.
- •(7)Unable to give informed consent.
- •(8)Already taking part in a research study.
研究者
相似试验
进行中（未招募）
不适用
Randomised controlled trials to investigate whether prophylactic antiobiotics can prevent further eisodes of cellulitis (erysipelas) of the leg (PATCH I & PATCH II). - PATCH I & PATCH IICellulitis of the legEUCTR2006-000381-36-IEniversity of Nottingham640
已完成
不适用
A randomized controlled trial to investigate whether "health beverage" improves obesity in humaHealthy adultsJPRN-UMIN000014167ORTHOMEDICO Inc.20
已完成
不适用
A randomized controlled trial to investigate whether decrease in visceral adipose tissue in humaHealthy adultsJPRN-UMIN000014526ORTHOMEDICO Inc.14
已完成
不适用
The impact of a positive psychology intervention on quality of life for women with polycystic ovary syndrome (PCOS)Polycystic ovarian syndromePolycystic Ovary Syndrome (PCOS)Nutritional, Metabolic, EndocrineISRCTN64066164niversity of Derby (UK)200
已完成
4 期
Individualised versus conventional enoxaparin dosing: a randomised controlled trialPulmonary EmbolismDeep Vein ThrombosisCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemAtrial FibrillationAcute Coronary SyndromeACTRN12608000573358School of Pharmacy22